Psilocybin for Depression
Psilocybin for Depression
About this item
Full title
Psilocybin for Depression
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2021-08, Vol.385 (9), p.862-864
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Carhart-Harris et al. (April 15 issue)
1
hypothesize that “equivalent efficacy (primary outcome) is predicted for . . . escitalopram vs. 25 mg psilocybin,” as stated in Section S2.1 in the Supplementary Appendix (available with the full text of the article at NEJM.org). They report power and statistical analyses for a superi...
Alternative Titles
Full title
Psilocybin for Depression
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2566045184
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2566045184
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2108082
How to access this item
Log in as a Library member
